Art
J-GLOBAL ID:201802271360122869   Reference number:18A1619825

BCL2 inhibitor ABT-199 and JNK inhibitor SP600125 exhibit synergistic cytotoxicity against imatinib-resistant Ph+ ALL cells

BCL2阻害剤ABT-199とJNK阻害剤SP600125はイマチニブ耐性pH+ALL細胞に対する相乗的細胞毒性を示す【JST・京大機械翻訳】
Author (12):
Material:
Volume: 15  Page: 69-75  Publication year: 2018 
JST Material Number: W3090A  ISSN: 2405-5808  Document type: Article
Article type: 原著論文  Country of issue: Netherlands (NLD)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Imatinib (IMT), a specific tyr...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1619825&from=J-GLOBAL&jstjournalNo=W3090A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (2):
JST classification
Category name(code) classified by JST.
Blood cell tumors(=neoplasms)  ,  Drug therapy(=pharmacotherapy)for tumors 

Return to Previous Page